Finance

Beta
Lists
ATHE:NASDAQ
Alterity Therapeutics Ltd
5,69 US$
-3,40%
(-0,20) 1D
7 ივლ, 15:10:04 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ATHE...
Open
5,76 US$
High
5,76 US$
Low
5,40 US$
Mkt. cap
103,54 მლნ.
Avg. vol.
79,16 ათ.
Volume
17,62 ათ.
52-wk high
7,00 US$
52-wk low
2,69 US$
EPS
-0,01 US$
Beta
0,28
Shares outstanding
18,13 მლნ.
No. of employees
9
Open
5,76 US$
High
5,76 US$
Low
5,40 US$
Mkt. cap
103,54 მლნ.
Avg. vol.
79,16 ათ.
Volume
17,62 ათ.
52-wk high
7,00 US$
52-wk low
2,69 US$
EPS
-0,01 US$
Beta
0,28
Shares outstanding
18,13 მლნ.
No. of employees
9
News stories
From sources across the web
About Alterity Therapeutics Ltd
CEO-
Employees9
Founded1997
Headquartersმელბურნი, ვიქტორიას შტატი, ავსტრალია
Sector-
Websitealteritytherapeutics.com
Analyst ratings
Based on 3 analysts giving stock ratings to ATHE in the past 3 months
Strong buy
Buy
3
Hold
0
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for ATHE in the last 3 months.
Highest
Current 5,69 US$
16,00 US$ (+181,20%)
Average
12,67 US$ (+122,67%)
Lowest
10,00 US$ (+75,75%)
Analyst
Recommendation
Action
Price target
Projected
Date
Debanjana Chatterjee
JonesTrading
Buy
Initiated
16,00 US$
+181,2%
06/29/2026
Caroline Palomeque
Ladenburg Thalmann & Co.
Buy
Initiated
10,00 US$
+75,7%
06/16/2026
Unknown Analyst
Ladenburg Thalmann & Co.
Buy
Initiated
10,00 US$
+75,7%
06/16/2026
Jason McCarthy
Maxim Group
Buy
Reiterated
12,00 US$
+110,9%
06/10/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in AUD
მარ. 2025
ივნ. 2025
სექ. 2025
დეკ. 2025
Revenue
1,92 მლნ.
1,92 მლნ.
1,40 მლნ.
1,40 მლნ.
Cost of goods sold
31,96 ათ.
31,96 ათ.
49,43 ათ.
49,43 ათ.
Cost of revenue
31,96 ათ.
31,96 ათ.
49,43 ათ.
49,43 ათ.
Research and development expenses
4,34 მლნ.
4,34 მლნ.
3,92 მლნ.
3,92 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,25 მლნ.
1,25 მლნ.
2,56 მლნ.
2,56 მლნ.
Operating expense
5,44 მლნ.
5,44 მლნ.
6,57 მლნ.
6,57 მლნ.
Total operating expenses
5,48 მლნ.
5,48 მლნ.
6,62 მლნ.
6,62 მლნ.
Operating income
-3,56 მლნ.
-3,56 მლნ.
-5,22 მლნ.
-5,22 მლნ.
Other non operating income
-163,27 ათ.
-163,27 ათ.
-
-
EBT including unusual items
-2,45 მლნ.
-2,45 მლნ.
-4,78 მლნ.
-4,78 მლნ.
EBT excluding unusual items
-3,55 მლნ.
-3,55 მლნ.
-4,78 მლნ.
-4,78 მლნ.
Income tax expense
34,03 ათ.
34,03 ათ.
30,78 ათ.
30,78 ათ.
Effective tax rate
-1,39%
-1,39%
-0,64%
-0,64%
Other operating expenses
15,36 ათ.
15,36 ათ.
95,67 ათ.
95,67 ათ.
Net income
-2,49 მლნ.
-2,49 მლნ.
-4,81 მლნ.
-4,81 მლნ.
Net profit margin
-129,78%
-129,78%
-343,00%
-343,00%
Earnings per share
-
-
-
-
Interest and investment income
167,50 ათ.
167,50 ათ.
454,88 ათ.
454,88 ათ.
Interest expense
-
-
-
-
Net interest expenses
167,50 ათ.
167,50 ათ.
454,88 ათ.
454,88 ათ.
Depreciation and amortization charges
-
-
-
-
EBITDA
-3,55 მლნ.
-3,55 მლნ.
-5,22 მლნ.
-5,22 მლნ.
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer